COLL - Company ID 0001267565
COLLEGIUM PHARMACEUTICAL, INC trades as COLL and has a market capitalization of $1.16 B, making it the #2546 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $780.57M, up 23.6% from the prior year and net income of $63.00M. This page tracks COLLEGIUM PHARMACEUTICAL, INC through 842 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-10
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years COLLEGIUM PHARMACEUTICAL, INC's revenue grew from $1.71M to $780.57M, a compound annual growth rate of 97.5%. Net profit margin expanded from -5504.1% to 8.1% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-18 |
| New insider ownership | 3 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
Collegium to Participate in 2026 Jefferies Global Healthcare Conference – Collegium Pharmaceutical Inc.
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics – Collegium Pharmaceutical Inc.
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress – Collegium Pharmaceutical Inc.
To access the conference call, please dial (877) 407-8037 ( U.S. ) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2026 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com . The webcast will be available for replay on the Company’s website approximately two hours after the event.
Collegium to Participate in Upcoming Investor Conferences – Collegium Pharmaceutical Inc.
The largest companies sharing COLLEGIUM PHARMACEUTICAL, INC's SEC industry classification (pharmaceutical preparations).
COLLEGIUM PHARMACEUTICAL, INC (COLL) has a market capitalization of $1.16 B as of 2026-07-10, ranking #2546 among US-listed companies.
COLLEGIUM PHARMACEUTICAL, INC reported revenue of $780.57M for fiscal year 2025, an increase of 23.6% year over year.
Yes. COLLEGIUM PHARMACEUTICAL, INC reported net income of $63.00M in its latest fiscal year.